Catalog · 7 compounds
Hormones & growth factors
Receptor pharmacology of hormone-releasing and growth-factor pathways, in cell and animal models.
A20-2020
Retatrutide
Fat Loss
Retatrutide is a synthetic investigational peptide designed as a single molecule acting at three receptors: GIP, GLP-1 and glucagon. It is a long synthetic chain carrying a fatty-acid modification that extends its half-life.
Receptor pharmacology · Incretin signalling · Metabolic regulation models
- CAS
- 2381089-83-2
- Formula
- C221H342N46O68
- MW
- 4731.33
- Purity
- ≥ 99.0 %
- 10 mg$80.00
- 20 mg$120.00
- 30 mg$160.00
A20-3040
Tesamorelin / Ipamorelin BlendBlend
Fat Loss
A supplier-defined blend of tesamorelin 10 mg and ipamorelin 5 mg in one lyophilized vial — note the components are not in equal amounts. Both are also listed individually in this catalog.
Mixture characterisation · Growth-hormone axis models
- CAS
- —
- Formula
- —
- MW
- —
- Purity
- ≥ 99.0 %
- 10 mg / 5 mg$120.00
A20-5010
Tesamorelin
Visceral Fat
Tesamorelin is a synthetic 44-amino-acid analogue of growth-hormone-releasing hormone, modified at one end with a trans-3-hexenoyl group to resist enzymatic breakdown. Laboratories use it as a defined agonist tool for studying the GHRH receptor and the growth-hormone axis.
GHRH receptor pharmacology · Growth-hormone axis models
- CAS
- 218949-48-5
- Formula
- C221H366N72O67S
- MW
- 5135.90
- Purity
- ≥ 99.0 %
- 10 mg$90.00
A20-5020
CJC-1295 DAC
GH Release
CJC-1295 with DAC is a synthetic analogue of a growth-hormone-releasing hormone fragment, carrying a Drug Affinity Complex group that binds serum albumin and greatly extends its circulating half-life. Laboratories use it as a long-acting GHRH-receptor agonist tool in endocrine signalling studies.
GHRH receptor pharmacology · Albumin-binding peptide design
- CAS
- 446262-90-4
- Formula
- C165H269N47O46
- MW
- 3647.20
- Purity
- ≥ 99.0 %
- 5 mg$65.00
A20-5030
Sermorelin
GH Release
Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of growth-hormone-releasing hormone, the shortest fragment that retains full receptor activity. Laboratories use it as a reference GHRH-receptor agonist in endocrine studies.
GHRH receptor pharmacology · Endocrine signalling models
- CAS
- 86168-78-7
- Formula
- C149H246N44O42S
- MW
- 3357.90
- Purity
- ≥ 99.0 %
- 10 mg$65.00
A20-5040
Ipamorelin
GH Release
Ipamorelin is a synthetic pentapeptide developed as a selective agonist at the growth-hormone secretagogue receptor (GHS-R1a), the receptor that also responds to the hormone ghrelin. That selectivity is what makes it useful in the laboratory: it isolates GHS-R1a signalling from other endocrine pathways in cell and animal models.
GHS-R1a receptor pharmacology · Ghrelin signalling · Endocrine models
- CAS
- 170851-70-4
- Formula
- C38H49N9O5
- MW
- 711.90
- Purity
- ≥ 99.0 %
- 10 mg$65.00
A20-5050
IGF-1 LR3
Muscle Growth
IGF-1 LR3 is an engineered analogue of insulin-like growth factor 1, a naturally occurring protein of 70 amino acids. The analogue carries a 13-residue extension at one end and a single substitution at position 3, changes that sharply reduce its binding to IGF-binding proteins.
IGF-1 receptor signalling · Cell culture supplementation
- CAS
- 946870-92-4
- Formula
- C400H625N111O115S9
- MW
- 9117.60
- Purity
- ≥ 99.0 %
- 1 mg$70.00
All items: research use only — not for human or veterinary use. Purchase requires a verified laboratory account.